JENNIFER KARNS: Open Payments
NPI 1205430410 · IDAHO FALLS, ID. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$289 in 8 payments from 5 companies in 2025. Trend: 2023 $94 · 2024 $569 · 2025 $289
Food & beverage: $257Education: $32
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 1 | $125 |
| ABBVIE INC. | 3 | $79 |
| Novo Nordisk Inc | 2 | $46 |
| Viatris Specialty LLC | 1 | $21 |
| Boston Scientific Corporation | 1 | $18 |
Products named: FANAPT, VRAYLAR, YUPELRI, QULIPTA, General - Pain Management, Wegovy.
Industry payments across ID — which companies pay providers there.
